Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

M2 antagonists reported by Yamanouchi

July 5, 1996

Kyowa Hakko's OXT displays cardiotonic and insulin release-promoting effects

July 5, 1996

NEP inhibitors claimed by Santen

July 5, 1996

AHP describes tricyclic benzazepine vasopressin antagonists

July 5, 1996

Alexion begins phase I testing of 5G1.1-SC

July 5, 1996

TMR with PLC Systems' Heart Laser continues to display efficacy

July 5, 1996

First launch for Ciba-Geigy angiotensin II antagonist

July 5, 1996

Warner-Lambert reports nonpeptide ET antagonists

July 5, 1996

Norvasc labeling revised by FDA

June 28, 1996

SmithKline Beecham antiarrhythmic research revealed

June 28, 1996

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...